Associate Professor, Center for Infectious Diseases, Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, UT Health Science Center at Houston
Molecular Pathology, Microbiology, and Molecular Genetics
The University of Texas Health Science Center at Houston
2012
MS
Biotechnology
Stephen F. Austin University
2008
MS
Biology
University of Bremen
2001
BS
Zoology/Biological Sciences
University of Ghana
1999
Research and Expertise
Research Interests
My laboratory focuses on microbial pathogenesis, molecular epidemiology, and molecular basis of enteric infectious diseases with the goal to identify and understand the mechanisms of action of novel virulence factors, pathways, and unique microbial products that can be harnessed for diagnostics and therapeutics. My long-term research interests include examining the role of microbially-produced small molecules and metabolites in the pathogenesis of enteric infectious diseases, mechanisms of host-pathogen interactions, antimicrobial resistance, host genetics and susceptibility to bacterial infections, and developing new genetic systems for bacterial pathogenesis studies. One of the current projects in my laboratory involves elucidating the mechanism of toxin regulation in Clostridium difficile, a multidrug-resistant pathogen responsible for majority of the hospital-acquired and antibiotic-associated diarrhea in the United States with an estimated total cost of treatment between 1 to 4.8 billion U.S. dollars annually. This anaerobic bacterium causes disease by producing toxins. To detect low levels of the toxins, we developed a sensitive assay that measures their enzymatic activity, which we anticipate will one day either replace or augment the current diagnostic methods. With this assay, we have discovered for the first time that C. difficile regulates the production of its disease-causing toxins using a unique small quorum-signaling cyclic peptide, which is released by the infecting bacteria and accumulates in the colon during infection. Furthermore, my laboratory has identified the novel pathway in C. difficile that is responsible for producing the cyclic peptide important for the production of its toxins. This has enabled us to identify novel compounds that block the pathway and hence, toxin production. We have also identified another group of compounds that inhibit toxin activity. These discoveries together, offer exciting new avenues both for rapid detection of C. difficile infections and development of novel non-antibiotic therapies for the treatment of both initial and recurrent C. difficile infections. A long-term goal of my laboratory is to understand all of the players and mechanisms involved in C. difficile toxin regulation, which I anticipate will allow us to develop novel therapeutics to combat this life-threatening emerging multidrug-resistant pathogen.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
GCC Cluster NanoX
Training Grants
Training Program in Antimicrobial Resistance (TPAMR)
Molecular Basis of Infectious Diseases Training Grant
Antimicrobial Resistance Training Program in the Texas Medical Center (AMR-TPT)
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.